-
Fast Five Quiz: Prostate Cancer and PSMA
26 Dec 2025 17:47 GMT
… and specific than standard bone scans, CT, and MRI … prostate cancer.
Learn more about the workup of prostate cancer. …
When determining whether a patient with prostate cancer … in detecting recurrent prostate cancer following primary treatment …
-
<![CDATA[Dr Freedland on the Next Steps for Evaluating Enzalutamide in Prostate Cancer]]>
08 Dec 2025 14:10 GMT
… , biochemically recurrent, nonmetastatic hormone-sensitive prostate cancer (nmHSPC) at high risk for … patients with no metastases on bone scans, CT scans, or MRIs per … of care in biochemically recurrent prostate cancer, Freedland stated. Topics that require …
-
<![CDATA[How clinicians navigate ARPI therapy in metastatic prostate cancer]]>
03 Dec 2025 21:34 GMT
… rapidly evolving management of metastatic prostate cancer, emphasizing practical decision-making, … patients with metastatic hormone-sensitive prostate cancer (mHSPC). Participants reaffirmed … previously undetectable by CT or bone scan. This imaging shift is …
-
<![CDATA[Optimizing Androgen Signaling Blockade in High-Risk Prostate Cancer]]>
02 Dec 2025 04:50 GMT
… for locally advanced prostate cancer and high-risk biochemically relapsed prostate cancer. The findings … scan or an abdomen or bone scan. But during the course of … clinically localised, and locally advanced prostate cancer: ENZARAD (ANZUP 1303). Presented at …
-
<![CDATA[Dr Freedland on the Increasingly Prominent Role of Enzalutamide in Prostate Cancer Treatment]]>
01 Dec 2025 15:29 GMT
… patients with no metastases on bone scans, CT scans, or MRIs per … results in a prostate cancer trial.
Freedland suggested that prostate cancer treatments in biochemically … best in recent years for prostate cancer Freedland stated. Considering the promising …
-
<![CDATA[Dr Freedland on the Efficacy Results From the EMBARK Trial of Enzalutamide in Prostate Cancer]]>
24 Nov 2025 17:40 GMT
… , Robertson, Law Families Chair in Prostate Cancer at Cedars-Sinai; as well … ) in patients with biochemically recurrent prostate cancer.
Protocol-defined on-trial treatment … that had no metastases on bone scans, CT scans, or MRIs per …
-
<![CDATA[Theranostic therapies expand frontline use in prostate cancer]]>
12 Nov 2025 02:33 GMT
… first-line settings for metastatic prostate cancer. Similarly, emerging data from the … backbone of treatment for prostate cancer, especially metastatic prostate cancer. I think that… we have are CT and bone scans for those patients. Now, we …
-
Prostate cancer: the silent threat that took Mr Z’s mobility and could jeopardise yours too
07 Nov 2025 14:21 GMT
… Significantly, I discovered that prostate cancer is not uncommon locally, … suggestive of advanced prostate cancer with spread to other … parent diagnosed with prostate cancer significantly increases your chances … as CT, PET and bone scans are employed to screen …
-
Dramatic Clinical Response to a Novel Form of Cell Therapy SL-28 in a Patient with Prostate Cancer and Bone Metastasis: A Case Report
28 Oct 2025 16:19 GMT
… 3 Bone scintigraphy (A) Baseline bone scans showing osteoblastic lesions at the … concerns and the nature of prostate tumors with bone metastasis, experimental SL … offer clinical benefit in advanced prostate cancer and warrants further clinical evaluation …
-
PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
24 Oct 2025 21:14 GMT
… .
“The treatment paradigm for advanced prostate cancer continues to evolve with the … with biochemical recurrence (BCR) of prostate cancer. They developed a decision-analytic … scans (CT and bone scan) were unclear and CT/bone scan alone. Lifetime …